TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30448455

Group type: EXPERIMENTAL
Intervention: Weight loss (≥5% weight loss in 1 year)
Number of subjects: 242

Group type: COMPARATOR
Intervention: No weight loss (<5% weight loss in 1 year)
Number of subjects: 242
Study: 28869119

Group type: EXPERIMENTAL
Intervention: Home-based pulmonary rehabilitation (3 sessions weekly for 8 weeks, aerobic exercise for 20min at 60-80% max stepping rate, resistance training with elastic band at 70% max voluntary isometric contraction)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard care (educational manual and recommendation to walk 3 times a week for 30min)
Number of subjects: 48
Study: 26375919

Group type: EXPERIMENTAL
Intervention: Resistance exercise (RESEX)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Concurrent exercise (CONCEX)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 34
Study: 23208878

Group type: EXPERIMENTAL
Intervention: New live tetravalent dengue virus vaccine
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 86
Study: 21810233

Group type: EXPERIMENTAL
Intervention: NEURAPAS® balance (6 tablets)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 19371497

Group type: EXPERIMENTAL
Intervention: Lorazepam (8 mg/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Chlordiazepoxide (80 mg/day)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 100

Group type: COMPARATOR
Intervention: Chlordiazepoxide
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 100
Study: 16413241

Group type: EXPERIMENTAL
Intervention: AVE7688 25 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AVE7688 5 mg
Number of subjects: 0
Study: 15571611

Group type: EXPERIMENTAL
Intervention: Ginger root powder 1 g/day for 5 days
Number of subjects: 48

Group type: COMPARATOR
Intervention: Metoclopramide (oral) for 4 days after placebo on the first day
Number of subjects: 48
Study: 10594428

Group type: EXPERIMENTAL
Intervention: Combined spinal-epidural group (n = 69)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Epidural group (n = 73)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 142
Study: 9339153

Group type: EXPERIMENTAL
Intervention: HVB suppositories
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: PGB suppositories
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: TVC mini-enemas
Number of subjects: 25
Study: 8232678

Group type: EXPERIMENTAL
Intervention: HELP treatment
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study: 3886069

Group type: EXPERIMENTAL
Intervention: Excision with suture (E + S)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Excision (E)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Excision with suture under cover with clindamycin (E + S + C)
Number of subjects: 88
Study: 31631005

Group type: EXPERIMENTAL
Intervention: Moderate intensity continuous exercise
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Higher intensity interval exercise
Number of subjects: 22

Group type: COMPARATOR
Intervention: Seated rest
Number of subjects: 22
Study: 30917079

Group type: EXPERIMENTAL
Intervention: Fingolimod
Number of subjects: 0

Group type: COMPARATOR
Intervention: IM IFNβ‐1a
Number of subjects: 0
Study: 27781297

Group type: EXPERIMENTAL
Intervention: Single MAC3.5 guiding catheter
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control group (diagnostic Tiger catheter first)
Number of subjects: 360
Study: 26694377

Group type: EXPERIMENTAL
Intervention: Darbepoetin α (DA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Continuous Erythropoietin Receptor Activator (CERA)
Number of subjects: 20
Study: 23395398

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 1103
Study: 21999340

Group type: EXPERIMENTAL
Intervention: Cyclosporine 0.05% (Cs-Cs)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Artificial tears (Cs-At)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Cyclosporine 0.05% after switching from artificial tears (At-Cs)
Number of subjects: 48
Study: 18652095

Group type: EXPERIMENTAL
Intervention: Tai Chi Chih
Number of subjects: 112

Group type: COMPARATOR
Intervention: Health education
Number of subjects: 112
Study: 17062808

Group type: EXPERIMENTAL
Intervention: Personalized Polar weight management program (PWMP)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 74
Study: 12619144

Group type: EXPERIMENTAL
Intervention: 12-week supervised aerobic exercise program
Number of subjects: 24

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 24
Study: 11199239

Group type: EXPERIMENTAL
Intervention: One-day workshop or two half-day workshops on cancer pain assessment and management
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Bedside-precepted visit with an oncology nurse specialist and focus group discussion
Number of subjects: 496

Group type: COMPARATOR
Intervention: Control group (86 nurses)
Number of subjects: 496
Study: 9425672

Group type: EXPERIMENTAL
Intervention: Oscillating walls in a moving room for 12 seconds
Number of subjects: 4
Study: 8281355

Group type: EXPERIMENTAL
Intervention: Perennial immunotherapy (602 BU cumulative dose)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Seasonal immunotherapy (372 BU cumulative dose)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no immunotherapy)
Number of subjects: 60
Study: 3549043

Group type: EXPERIMENTAL
Intervention: Aprindine
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study: 30525790

Group type: EXPERIMENTAL
Intervention: Family Connects (bottom-up approach with brief home visits)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: North Carolina Smart Start Initiative (top-down approach to improve community-level quality of early childcare and education services)
Number of subjects: 0
Study: 28578704

Group type: EXPERIMENTAL
Intervention: Marine Phospholipids (MPL) supplementation at 0.3 g of n-3-fatty acids per day for six weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fish Oil (FO) supplementation at 0.3 g of n-3-fatty acids per day for six weeks
Number of subjects: 60
Study: 24722788

Group type: EXPERIMENTAL
Intervention: Navigation system
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 38
Study: 23849948

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting with ARWMC score of 7 or more
Number of subjects: 1036

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting with ARWMC score of less than 7
Number of subjects: 1036

Group type: COMPARATOR
Intervention: Carotid endarterectomy with ARWMC score of 7 or more
Number of subjects: 1036

Group type: COMPARATOR
Intervention: Carotid artery stenting compared to carotid endarterectomy in patients with ARWMC score of 7 or more
Number of subjects: 1036

Group type: COMPARATOR
Intervention: Carotid endarterectomy with ARWMC score of less than 7
Number of subjects: 1036
Study: 20679165

Group type: EXPERIMENTAL
Intervention: 9-month mentoring and skills group program
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control group (assessment only)
Number of subjects: 156
Study: 19142359

Group type: EXPERIMENTAL
Intervention: Surgery without extracorporeal circulation (WECC)
Number of subjects: 259

Group type: COMPARATOR
Intervention: Surgery with extracorporeal circulation (SECC)
Number of subjects: 259
Study: 16344336

Group type: EXPERIMENTAL
Intervention: Testosterone therapy (75 mg hydroalcoholic gel applied daily)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 38
Study: 14583904

Group type: COMPARATOR
Intervention: Increased left ventricular wall thickness (LVH) in group A (30%) versus group B (18%)
Number of subjects: 562

Group type: COMPARATOR
Intervention: Overall mortality rate in group A (17%) versus group B (22%)
Number of subjects: 562

Group type: COMPARATOR
Intervention: Odds of having LVH in group A versus group B
Number of subjects: 562

Group type: COMPARATOR
Intervention: Calculated mean LV mass
Number of subjects: 562
Study: 10672136

Group type: EXPERIMENTAL
Intervention: Interventions supported by randomized controlled trials
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Interventions supported by consensus among experienced clinicians
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Interventions in patients with cardiac diagnoses
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Interventions in patients with other circulatory diagnoses
Number of subjects: 197
Study: 7618543

Group type: EXPERIMENTAL
Intervention: Three-dimensional turbo spin-echo MR cholangiopancreatography
Number of subjects: 30

Group type: COMPARATOR
Intervention: Endoscopic or percutaneous cholangiopancreatography
Number of subjects: 30
Study: 2189617

Group type: COMPARATOR
Intervention: Quinapril (20, 40, 80 mg/day, once or twice daily)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Quinapril (10-40 mg/day, once or twice daily)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Quinapril (10, 20, and 40 mg/day, with optional titration)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Quinapril
Number of subjects: 270
Study: 666189

Group type: EXPERIMENTAL
Intervention: Ultrasonic cholangiography (official reading)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Ultrasonic cholangiography (blind reading)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Ultrasonic cholangiography
Number of subjects: 47
Study: 31136543

Group type: EXPERIMENTAL
Intervention: Traditional training (TT)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Cluster training (CT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 35
Study: 31151199

Group type: EXPERIMENTAL
Intervention: Krill oil supplementation (400 mg EPA and DHA per day)
Number of subjects: 267

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Krill oil supplementation (800 mg EPA + DHA per day)
Number of subjects: 267
Study: 27752842

Group type: EXPERIMENTAL
Intervention: Multimedia assessment
Number of subjects: 88

Group type: COMPARATOR
Intervention: Text-based assessment
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Multimedia assessment for respiratory questions
Number of subjects: 88

Group type: COMPARATOR
Intervention: Text-based assessment for respiratory questions
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Multimedia assessment for dermatology questions
Number of subjects: 88

Group type: COMPARATOR
Intervention: Text-based assessment for dermatology questions
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Correlation of ITE scores with text-based scores
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Correlation of ITE scores with multimedia scores
Number of subjects: 88
Study: 26016823

Group type: EXPERIMENTAL
Intervention: Lung volume reduction surgery (LVRS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no immediate LVRS)
Number of subjects: 30
Study: 23158959

Group type: EXPERIMENTAL
Intervention: ECT
Number of subjects: 529

Group type: COMPARATOR
Intervention: Non-ECT
Number of subjects: 529
Study: 21513473

Group type: EXPERIMENTAL
Intervention: Living Cellular Construct (LCC)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Free Gingival Graft (FGG)
Number of subjects: 96
Study: 18291168

Group type: EXPERIMENTAL
Intervention: Cell-seeded collagen matrix
Number of subjects: 20

Group type: COMPARATOR
Intervention: No matrix
Number of subjects: 20
Study: 17183729

Group type: EXPERIMENTAL
Intervention: High dose simvastatin (80 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atorvastatin (40 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 14505903

Group type: EXPERIMENTAL
Intervention: FLUAD
Number of subjects: 301

Group type: COMPARATOR
Intervention: Fluzone
Number of subjects: 301
Study: 10750576

Group type: EXPERIMENTAL
Intervention: Neridronate (50 mg iv every 2 months for a year)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 87
Study: 9117754

Group type: EXPERIMENTAL
Intervention: 5% Amlexanox oral paste
Number of subjects: 1335

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 1335
Study: 8362449

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ) once weekly
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Proguanil (PROG) daily
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Combination of Chloroquine and Proguanil (CQ + PROG)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 312
Study: 3095780

Group type: EXPERIMENTAL
Intervention: Selective antimicrobial modulation of the intestinal flora (SAM) with trimethoprim-sulfamethoxazole
Number of subjects: 65

Group type: COMPARATOR
Intervention: Total antibiotic decontamination (TAD) with gentamicin, vancomycin and colimycin
Number of subjects: 65
Study: 30854705

Group type: EXPERIMENTAL
Intervention: Bovine dermis-derived collagen membrane (test group)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Bio-Gide (control group)
Number of subjects: 36
Study: 29492615

Group type: EXPERIMENTAL
Intervention: 30 mg oral GR3027
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3 mg oral GR3027
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26383833

Group type: EXPERIMENTAL
Intervention: BRAID (web-based breast reconstruction decision support aid)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Pamphlet (Cancer Support Community's Frankly Speaking About Cancer: Breast Reconstruction)
Number of subjects: 55
Study: 24898643

Group type: EXPERIMENTAL
Intervention: Donepezil + Choline Alphoscerate
Number of subjects: 113

Group type: COMPARATOR
Intervention: Donepezil + Placebo
Number of subjects: 113
Study: 23035890

Group type: EXPERIMENTAL
Intervention: Endoscopic strategies
Number of subjects: 197910

Group type: COMPARATOR
Intervention: Faecal tests
Number of subjects: 197910

Group type: EXPERIMENTAL
Intervention: FIT (Fecal Immunochemical Test)
Number of subjects: 197910

Group type: COMPARATOR
Intervention: g-FOBT (guaiac-based fecal occult blood test)
Number of subjects: 197910
Study: 20360151

Group type: EXPERIMENTAL
Intervention: Lifestyle Counts intervention (lifestyle change classes for eight weeks, goal-setting, and telephone follow-up for three months)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Attention-control group (equivalent amount of contact in classes on general disease-related information and health education topics, unstructured follow-up phone calls)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Lifestyle Counts intervention
Number of subjects: 187

Group type: COMPARATOR
Intervention: Attention-control group
Number of subjects: 187
Study: 18552672

Group type: EXPERIMENTAL
Intervention: Sequestrectomy
Number of subjects: 174

Group type: COMPARATOR
Intervention: Control (standard microsurgical treatment)
Number of subjects: 174
Study: 15855347

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 3234

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 3234

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3234
Study: 12455074

Group type: EXPERIMENTAL
Intervention: Probucol
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control
Number of subjects: 78
Study: 10348768

Group type: EXPERIMENTAL
Intervention: Amphotericin B in 5% dextrose
Number of subjects: 61

Group type: COMPARATOR
Intervention: Amphotericin B in fat emulsion (Intralipid)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 61
Study: 8769206

Group type: EXPERIMENTAL
Intervention: Neoral therapy
Number of subjects: 0
Study: 1385658

Group type: EXPERIMENTAL
Intervention: Graded activity program with a behavioral therapy approach (n = 51)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Traditional care (Control group, n = 52)
Number of subjects: 103
Study: 6093960

Group type: EXPERIMENTAL
Intervention: Ranitidine 100 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Ranitidine 50 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Cimetidine 300 mg
Number of subjects: 120
Study: 30272245

Group type: EXPERIMENTAL
Intervention: Active V1 subcutaneous trigeminal nerve stimulation (sTNS) as adjuvant to medical therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Continuous sTNS
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Open-label phase following the initial trial
Number of subjects: 20
Study: 28751267

Group type: EXPERIMENTAL
Intervention: Ice water test (4C)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Warm water test (36C)
Number of subjects: 40
Study: 26018041

Group type: EXPERIMENTAL
Intervention: Strategic Memory Advanced Reasoning Training (SMART)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Brain Health Workshop (BHW)
Number of subjects: 60
Study: 24799513

Group type: EXPERIMENTAL
Intervention: Greater total leisure-time activity
Number of subjects: 985

Group type: EXPERIMENTAL
Intervention: Greater walking distance
Number of subjects: 985

Group type: EXPERIMENTAL
Intervention: Greater walking pace
Number of subjects: 985
Study: 22417137

Group type: EXPERIMENTAL
Intervention: Phase 1 HQID
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Phase 2 HQID
Number of subjects: 4

Group type: COMPARATOR
Intervention: Phase 1 and Phase 2 HQID
Number of subjects: 4
Study: 20096909

Group type: EXPERIMENTAL
Intervention: Praneem polyherbal tablet
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 17868127

Group type: EXPERIMENTAL
Intervention: Anorexia nervosa (AN)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Anorexia nervosa - binge eating purging subtype (AN-BP)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Bulimia nervosa (BN)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Major depression (DEP)
Number of subjects: 56
Study: 16026378

Group type: EXPERIMENTAL
Intervention: Low-risk group with protective factors (BMI < 25 kg/m(2), waist-hip ratio < 0.85 for women and 0.90 for men, never smoking, medium to high physical activity, light drinking, prudent dietary pattern)
Number of subjects: 1018

Group type: EXPERIMENTAL
Intervention: Low-risk group with protective factors
Number of subjects: 1018

Group type: COMPARATOR
Intervention: None of the protective factors
Number of subjects: 1018

Group type: EXPERIMENTAL
Intervention: One protective factor
Number of subjects: 1018

Group type: EXPERIMENTAL
Intervention: Two protective factors
Number of subjects: 1018

Group type: EXPERIMENTAL
Intervention: Three protective factors
Number of subjects: 1018

Group type: EXPERIMENTAL
Intervention: Four protective factors
Number of subjects: 1018

Group type: EXPERIMENTAL
Intervention: Five protective factors
Number of subjects: 1018

Group type: EXPERIMENTAL
Intervention: Six protective factors
Number of subjects: 1018
Study: 12476932

Group type: EXPERIMENTAL
Intervention: Prednisolone, 20 mg twice daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 10330639

Group type: EXPERIMENTAL
Intervention: Intracameral injection of 0.5 mL lidocaine 1%
Number of subjects: 10
Study: 8955574

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Injective immunotherapy
Number of subjects: 20
Study: 1836290

Group type: EXPERIMENTAL
Intervention: 10 mcg recombinant DNA yeast-derived hepatitis B vaccine
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: 20 mcg recombinant DNA yeast-derived hepatitis B vaccine
Number of subjects: 314

Group type: COMPARATOR
Intervention: Both doses (10 mcg and 20 mcg)
Number of subjects: 314
Study: 7425396

Group type: EXPERIMENTAL
Intervention: Group I (11 patients receiving injections for the first time)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Group II (20 patients already receiving injections)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Group III (20 control patients who did not receive any injections)
Number of subjects: 51
Study: 31274231

Group type: EXPERIMENTAL
Intervention: E39 + GM-CSF vaccine (1000 μg)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: E39 + GM-CSF vaccine (<1000 μg)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: E39 + GM-CSF vaccine (any dose)
Number of subjects: 51
Study: 28696286

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin treatment (24 International Units, twice daily for 4 weeks)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 32
Study: 25282519

Group type: EXPERIMENTAL
Intervention: Evolocumab 140 mg every 2 weeks
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Evolocumab 420 mg monthly
Number of subjects: 331

Group type: COMPARATOR
Intervention: Placebo every 2 weeks
Number of subjects: 331

Group type: COMPARATOR
Intervention: Placebo monthly
Number of subjects: 331
Study: 25076659

Group type: EXPERIMENTAL
Intervention: Rice-based fortified complementary food and nutrition education (Cf)
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Sprinkle and nutrition education (Mp)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Nutrition education alone (Ed)
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Fortified complementary food (Cf)
Number of subjects: 292
Study: 22931630

Group type: EXPERIMENTAL
Intervention: Furosemide plus albumin
Number of subjects: 24

Group type: COMPARATOR
Intervention: Furosemide alone
Number of subjects: 24
Study: 22254067

Group type: EXPERIMENTAL
Intervention: Individualised fracture risk feedback based on bone mineral density (BMD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Osteoporosis Prevention and Self‐Management Course (OPSMC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium supplements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-reported physical activity change
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Receiving the OPSMC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Feedback of high fracture risk
Number of subjects: 0
Study: 16893523

Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 163

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study: 16372516

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Statins (pooled data)
Number of subjects: 70